Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Controlled Trial to Compare the Safety and Efficacy of siroliMUs-eLuTIng Biodegradable Polymer ulTrA-thin Stent (SUPRAFLEX Cruz) and Everolimus-eLuting Biodegradable Polymer Stent (SYNERGY) in treatmENT for Three-vessel Coronary Artery Disease: Multivessel TALENT

NCT04390672 is registered in ClinicalTrials.gov with National University of Ireland, Galway, Ireland as lead sponsor.

NCT NCT04390672
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04390672 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Controlled Trial to Compare the Safety and Efficacy of siroliMUs-eLuTIng Biodegradable Polymer ulTrA-thin Stent (SUPRAFLEX Cruz) and Everolimus-eLuting Biodegradable Polymer Stent (SYNERGY) in treatmENT for Three-vessel Coronary Artery Disease: Multivessel TALENT
Lead sponsor
National University of Ireland, Galway, Ireland
Phase
Not applicable
Overall status
Active, not recruiting
Start date
September 22, 2020
Completion date
September 30, 2026
Enrollment
1,550 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

arterial occlusive diseases, cardiovascular diseases, coronary artery disease, coronary disease, heart diseases, myocardial ischemia, vascular diseases